In Stuttgart on the next day, Fraunhofer IGB (Institute for Interfacial Engineering and Biotechnology) will give insights into processes and technologies in the business fields of healthcare, nutrition, environment, and sustainable and functional products being developed and optimized there. After networking, the group will have a stop at Pharmacy Museum Heidelberg.
Fraunhofer IPA (Institute for Manufacturing Engineering and Automation) in Mannheim will present its project group PAMB. It develops novel automation solutions for medicine and biotechnology in a wide spectrum of research and development services. The Max Planck Institute (MPI) for Experimental Medicine in Göttingen, which the delegation will visit next, stands for basic research in neurosciences and oncology.
Day 4 of InnoTour 2018 will be at Fraunhofer ITEM (Institute for Toxicology and Experimental Medicine) in Hannover. This stop will include a visit to the adjacent Clinical Research Center Hannover (CRC Hannover), whose state-of-the-art infrastructure is being shared by Fraunhofer ITEM, the Hannover Medical School (MHH) and the Helmholtz Center for Infection Research (HZI) to perform safety and efficacy trials with candidate drugs, patient-oriented research, and epidemiological studies.
On the last morning, the Australian experts will visit the Fraunhofer-inHaus-Center in Duisburg, an innovation center for novel system solutions in rooms and buildings. Stryker GmbH, in Duisburg as well, will be the last stop of the tour. Markus Wiegmann, Managing Director, will welcome the Australian group, presenting the company’s activities in the field of medical technology.
Fraunhofer Institute for Toxicology and Experimental Medicine